Close X
Attorney Spotlight

How does Jessie Zeigler anticipate the intersection of privacy and smart technology will impact the future of litigation? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Healthcare Private Equity Compliance Checklist

The complex and ever-changing healthcare regulatory and enforcement environment, including increased focus on the role of private equity firms in their portfolio companies, make compliance a top priority for private equity firms investing in healthcare companies. The best way to limit your exposure as a private equity firm is to avoid a compliance misstep in the first place. Additionally, an effective and robust compliance program for your portfolio healthcare company makes it much more attractive to potential buyers and helps you avoid an unexpected and costly investigation or valuation hit down the road. Download the Healthcare Private Equity Compliance Checklist to assess whether your portfolio company's compliance program is up-to-date.

Click here to download the checklist.

Pennsylvania Will Enforce Non-Resident Pharmacy Licensure Requirement Beginning December 7, 2015

Publications

November 23, 2015

The Pennsylvania Board of Pharmacy has indicated its intent to begin enforcement of Pennsylvania's new non-resident pharmacy licensure requirement on December 7, 2015. Non-resident pharmacies with Pennsylvania operations should apply for a non-resident pharmacy license as soon as possible. The application is available through the Board's website and requirements include, among other things:

  • the submission of a $125 fee;

  • a copy of the pharmacy's resident state license;

  • the provision of a letter of good standing or license verification from the resident state Board of Pharmacy directly to the Pennsylvania Board; and

  • a copy of a sample prescription label including the pharmacy's toll-free phone number.

On October 7, 2015, Pennsylvania enacted legislation requiring non-resident pharmacies to register with the Pennsylvania Board of Pharmacy before delivering prescriptions to Pennsylvania patients or advertising in Pennsylvania.

To ensure compliance and prevent any disruption to operations, out-of-state pharmacies currently shipping product to Pennsylvania patients should apply for Pennsylvania licensure as soon as possible. Regulators have advised pharmacies to allow at least two weeks for the processing of applications, meaning pharmacies should attempt to submit their applications by November 23, 2015.

Pennsylvania does not require that the non-resident pharmacy's designated pharmacist-in-charge hold a Pennsylvania pharmacist license.

As noted in our previous alert, the licensure requirement will create new compliance obligations for non-resident pharmacies with operations in Pennsylvania.

If you have questions about Pennsylvania's new non-resident licensure requirement, please contact the authors of this alert or any member of our Specialty Pharmacy team.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.